ODDB.org: Open Drug Database | Medikamente

Limitationstexte "v", 81 von Total 1912.

	Name
A \| B \| C \| D \| E \| F \| G \| H \| I \| J \| K \| L \| M \| N \| O \| P \| Q \| R \| S \| T \| U \| V \| W \| X \| Y \| Z
L	Valaciclovir Sandoz 500 mg
L	Valaciclovir Therica 500 mg
L	Valaciclovir Zentiva
L	Valaciclovir-Mepha 1000
L	Valacivir-Mepha 500 mg
L	Valdoxan 25 mg
L	Valium Roche 10 mg
L	Valium Roche 5 mg
L	Valsartan Amlo Spirig HC 10/160mg
L	Valsartan Amlo Spirig HC 5/160mg
L	Valsartan Amlo Spirig HC 5/80mg
L	Vancocin 125 mg
L	Vancocin 250 mg
L	Vancomycin Labatec 1 g
L	Vancomycin Labatec 500 mg
L	Varitect CP
L	Vascord 20mg/5mg
L	Vascord 40mg/10mg
L	Vascord 40mg/5mg
L	Vascord HCT 20/5/12.5mg
L	Vascord HCT 40/10/12.5mg
L	Vascord HCT 40/10/25mg
L	Vascord HCT 40/5/12.5mg
L	Vascord HCT 40/5/25mg
L	Vaxelis 0.5 ml
L	VaxigripTetra
L	Vectibix 100 mg/5 ml
L	Vectibix 400 mg/20 ml
L	Velcade 1 mg
L	Velcade 3.5 mg
L	Velphoro
L	Veltassa 16.8 g
L	Veltassa 8.4 g
L	Venclyxto 10 mg
L	Venclyxto 100 mg
L	Venclyxto 50 mg
L	Ventavis
L	Verzenios 100 mg
L	Verzenios 150 mg
L	Verzenios 200 mg
L	Verzenios 50 mg
L	Vesanoid
L	VEYVONDI 1300 IE
L	VEYVONDI 650 IE
L	Vi-De 3 Monatsdosis
L	Victoza 6 mg/ml
L	Vidaza 100 mg
L	Viferol D3 25'000 UI/ml
L	Vimpat 10 mg/ml
L	Vimpat 100 mg
L	Vimpat 150 mg
L	Vimpat 200 mg
L	Vimpat 50 mg
L	Vipdomet 12.5 mg / 1000 mg
L	Vipdomet 12.5 mg / 850 mg
L	Vipidia 12.5mg
L	Vipidia 25 mg
L	Vipidia 6.25 mg
L	Visipaque 270 mg/mL
L	Visipaque 320 mg/mL
L	Visudyne
L	Vitamin D3 Spirig HC 2740 I.E./ml
L	Vitamin D3 Spirig HC
L	Vizimpro 15 mg
L	Vizimpro 30 mg
L	Vizimpro 45 mg
L	Vokanamet 150 mg / 1000 mg
L	Vokanamet 150 mg / 850 mg
L	Vokanamet 50 mg / 1000 mg
L	Vokanamet 50 mg / 850 mg
L	Volibris 10 mg
L	Volibris 5 mg
L	Voncento 1000/2400 I.E., Pulver und Lösungsmittel (10 ml) zur Herstellung einer Infusionslösung
L	Voncento 500/1200 I.E., Pulver und Lösungsmittel (5 ml) zur Herstellung einer Infusionslösung
L	Votrient 200 mg
L	Votrient 400 mg
L	Votubia 2 mg
L	Votubia 2.5 mg
L	Votubia 3 mg
L	Votubia 5 mg
L	VPRIV 400 U

Legende einblenden

2021	©ywesee GmbH